
Dr. Ashok Seth
Chairman
46+ Years of ExperienceInterventional Cardiologist
MBBS, MRCP, FESC
Reg. No.:6648 Delhi Medical Council, 2000
Fortis Escorts Heart Institute, New Delhi
English, Hindi
Consultation Fee ₹ 5000

About Dr. Ashok Seth
Dr. Ashok Seth, currently the Chairman of Cardiac Sciences at Fortis Escorts, also chairs the Fortis Healthcare Cardiology Council. He is Adjunct Professor of Cardiology at JN Medical College, Aligarh Muslim University. He pioneered interventional cardiology in India and the Asia Pacific, returning from the UK in 1988 to establish India’s first invasive cardiology programme. He is one of the best heart doctors in Delhi.
Dr. Ashok Seth’s Expertise & Specialisations
- Complex Coronary Angioplasties: Dr. Ashok Seth, Interventional Cardiologist, has performed more than 60,000 angiographies and over 25,000 angioplasties during his career, and his achievements have been recognized in the Limca Book of Records.
- Advanced Techniques: He was the first in the region to perform procedures such as angioscopy, directional atherectomy, thrombectomy, Impella-supported angioplasty, and the use of drug-eluting and bioresorbable stents.
- Structural Interventions: Dr. Seth is proficient in advanced structural interventions like Transcatheter Aortic Valve Implantation (TAVI), MitraClip implantation, tricuspid valve procedures, and various peripheral vascular interventions.
- High-risk Cases: Dr. Ashok Seth at Fortis Escorts has managed some of the most complex and high-risk cardiac cases, including rotational and orbital atherectomy, intravascular lithotripsy (IVL), percutaneous myocardial laser revascularisation, and aneurysm or stent graft procedures.
- Academic Leadership: As a thought leader, he has directed major live cardiology courses, including India Live, AsiaPCR, India Valves, and CHIP-CTO. In addition to training over 500 cardiologists, he has authored more than 500 publications and edited three authoritative cardiology textbooks.
Top Procedures Performed by Dr. Ashok Seth and Their Costs
Here are some commonly performed procedures by Dr. Ashok Seth, the best Interventional Cardiologist in Delhi.
Procedure |
Approx. Cost (INR) |
Approx. Cost (USD) |
Complex Coronary Angioplasty (atherectomy, Impella) |
200,000–500,000 |
2,400–6,000 |
TAVI / Structural Valve Procedures |
1,000,000–,800,000 |
12,000–21,600 |
IVL, Laser Revascularisation, Atherectomy |
400,000–800,000 |
4,800–9,600 |
Note: Costs depend on case complexity, hospital protocols.
Some Noteworthy Patient Reviews for Dr. Ashok Seth
Dr. Ashok Seth's reviews often highlight expert, cynical care. Dr. Ashok Seth, often referred to as the top cardiologist in Delhi and the best Heart doctor in Delhi, combines over 46 years of pioneering interventional cardiology with a strong academic and research legacy.
“He performed my father's complex angioplasty with such precision that recovery was smoother than expected. His expertise is truly reassuring."
"From diagnosis to discharge, Dr. Ashok Seth and his team ensured I was well-informed and comfortable. His calm demeanor gave us confidence throughout."
"After being turned away elsewhere for a high-risk case, Dr. Ashok Seth, the best Interventional Cardiologist in Delhi, gave me a second chance. I’m living proof of his skill and commitment to patient care."
To book an appointment with Dr. Ashok Seth or inquire about Dr. Ashok Seth's contact number, please contact MediJouney. You can also contact the Fortis Escorts Cardiology Department or visit the hospital’s website.
Book Your Appointment With Dr. Ashok Seth
Get a Treatment Plan Within 1 Hour
Education
- MBBS – JN Medical College, Aligarh Muslim University, 1978
- Honorary Degrees: DSc (BHU, AMU, Amity, TMU, Shiv Nadar U), DLitt (Jamia Millia Islamia)
- First Asian on SCAI Board; associate editor/journal board member (JACC, EuroIntervention, Catheterisation & Cardiovascular Interventions)
Training & Certificates
- MRCP - Royal Colleges of Physicians & Surgeons in Ireland, 1986
- Doctor of Science (DSc.) - Banaras Hindu University, 1998
- Fellowship of the European Society of Cardiology (FESC) - European Society of Cardiology, 1995
Past Experience
- Cardiologist, Queen Elizabeth Hospital, Birmingham (1983–1988)
- Chief, Interventional Cardiology, Escorts Heart Institute (1988–2004)
- Chief, Max Heart & Vascular Institute (2004–2008)
- Chairman, Cardiac Sciences & Cardiology Council, Fortis Escorts (2008–present)
Awards
- Padma Shri (2003), Padma Bhushan (2015)
- B.C. Roy National Award: Eminent Medical Person (2017)
- Order of Isabella the Catholic (Spain, 2010); Master Interventionalist (MSCAI, USA); Lifetime Achievement (Chien Foundation)
- Featured among healthcare “25 Changemakers” (Outlook 2023), “AMU Top 100 Alumni”
Associations/Membership
- President, Asian Pacific Society of Interventional Cardiology (APSIC)
- Past President & Vice President, Cardiological Society of India
- Board Member, SCAI (USA); Advisory roles: TCT, EuroPCR, ACC India, CSI, SAARC societies
Paper Published
- Safety and effectiveness of the novel Myval Octacor transcatheter heart valve in severe, symptomatic aortic valve stenosis — A real-world Indian experience (The OCTACOR India Study), 2024
- Última generación de prótesis percutáneas expandibles con balón y autoexpandibles en la estenosis aórtica bicúspide: estudio TRITON,2023
- Angiographic quantification of aortic regurgitation following removal of octacor implantation; independent core lab adjudication, 2023
- One-Year Outcomes after Myval Implantation in Patients with Bicuspid Aortic Valve Stenosis Multicentre Real-World Experience, 2023
- Transcatheter valve-in-valve or valve-in-ring implantation with a novel balloon-expandable device in patients with bioprosthetic left-sided heart valve failure: 1-year follow-up from a multicenter experience, 2023
- Prosthetic valve thrombosis secondary to heparin-induced thrombocytopenia - Double trouble, 2022
- Clinical expert consensus document on the use of percutaneous left ventricular assist devices during complex, high-risk PCI in India using a standardized algorithm, 2022
- Transcatheter Aortic Valve Implantation for Severe Bicuspid Aortic Stenosis - 2 Years Follow-up Experience From India, 2022
- Journal Pre-proof Impact of the 2017 ACC/AHA Guidelines on the Prevalence of Hypertension Among Indian Adults: Results from a Cross-Sectional Survey, 2020
- Evaluation of Balloon Expandable Transcatheter Heart Valve in the Treatment of Severe Symptomatic Native Aortic Stenosis: The First-in-human MyVal-1 Study, 2020
- First-in-Human Evaluation of Balloon Expandable Transcatheter Heart Valve in the Treatment of Severe Symptomatic Native Aortic Stenosis: The MyVal-1 Study, 2019
- Prevalence of Hypertension among Indian Adults: Results from the Great India Blood Pressure Survey, 2019
- Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial, 2019
- Chronic total occlusion or non-Chronic total occlusion percutaneous coronary intervention: Do myocytes care, 2019
- TCT-64 Two-Year Clinical and Imaging Outcomes of Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffolds in De Novo Coronary Artery Lesions: The MeRes-1 Trial, 2018
- Long-term follow-up of BVS from a prospective multicenter registry: Impact of a dedicated implantation technique on clinical outcomes, 2018
- TCTAP A-052 Long-term Outcomes and Technical Challenges of Treating Diffuse Coronary Artery Disease with Everolimus-eluting Bioresorbable Vascular Scaffolds, 2018
- 1968Quantitative angiographic analysis in patients with de novo native coronary artery lesions treated with novel poly-l-lactide based sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 Trial, 2017
- First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the treatment of de novo native coronary artery lesions: MeRes-1 trial, 2017
- TCTAP A-003 First-in-human Evaluation of a Novel Poly-L-lactide Based Sirolimus-eluting Bioresorbable Vascular Scaffold for the Treatment of De Novo Native Coronary Artery Lesions: MeRes-1 Trial, 2017
- TCTAP A-058 Favorable Outcomes for Systemic Pharmacokinetic Study of Sirolimus-eluting Bioresorbable Vascular Scaffold System in Treating De Novo Native Coronary Artery Lesion: A Sub-Study of MeRes-1 Trial, 2017
- CRT-700.04 Three-year Clinical Outcomes Of Biomime Sirolimus-eluting Coronary Stent System With A Biodegradable Polymer In Coronary Artery Disease Patients: A Long-term Follow-up Of The meriT-2 Study, 2017
- CRT-700.01 Favourable Outcomes for Systemic Pharmacokinetic Study of Sirolimus-Eluting BioResorbable Vascular Scaffold System in Treating de novo Native Coronary Artery Lesion: A Sub Study of MeRes-1 Trial, 2017
- TCT-434 Implantation of Absorb Bioresorbable Vascular Scaffolds in Small Vessel Coronary Artery Disease: Long-term follow-up, 2016
- TCTAP A-004 Rotational Atherectomy and Stenting of Severely Calcified Coronary Arteries with Absorb Bioresorbable Vascular Scaffolds: Analysis of Outcomes, 2016
- TCTAP A-054 Long-term Outcome Analysis of Stenting of Diffuse Coronary Lesions with Absorb Bioresorbable Vascular Scaffolds, 2016
- Late angiographic and clinical outcomes of the novel BioMime™ sirolimus-eluting coronary stent with ultra-thin cobalt-chromium platform and biodegradable polymer for the treatment of diseased coronary vessels: results from the prospective, multicentre meriT-2 clinical trial, 2016
- Late angiographic and clinical outcomes of the novel BioMime™ sirolimus-eluting coronary stent with ultra-thin cobalt-chromium platform and biodegradable polymer for the treatment of diseased coronary vessels: results from the prospective, multicentre meriT-2 clinical trial, 2016
- Late angiographic and clinical outcomes of the novel BioMime™ sirolimus-eluting coronary stent with ultra-thin cobalt-chromium platform and biodegradable polymer for the treatment of diseased coronary vessels: results from the prospective, multicentre meriT-2 clinical trial, 2016
- Late angiographic and clinical outcomes of the novel BioMime™ sirolimus-eluting coronary stent with ultra-thin cobalt-chromium platform and biodegradable polymer for the treatment of diseased coronary vessels: results from the prospective, multicentre meriT-2 clinical trial, 2015
- Salvage of Side Branch by Provisional "TAP Technique" Using Absorb (TM) Bioresorbable Vascular Scaffolds for Bifurcation Lesions: First Case Reports with Technical Considerations, 2014
- Use of 'Guidelines' catheter to overcome the failure of delivery of Absorb™ Bioresorbable Vascular Scaffold in calcified tortuous coronary lesions: Technical considerations in 'Real World Patients,' 2014
- One-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis of the ABSORB and the SPIRIT Trials, 2014
- TCT-212 Efficacy of the Novel BioMime Sirolimus-Eluting Stents with a Biodegradable Polymer in the Treatment of De Novo Coronary Lesions: An Angiographic Subanalysis of the Combined meriT-1 and meriT-2 Prospective Clinical Trials, 2013
- TCT-36 One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSORB EXTEND Trials., 2013
- The Paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: An angiographic follow-up study, 2013
- TCT-649 Safety and Efficacy of Overlapping Second Generation Drug-Eluting Stents Based Upon 2-year Clinical Outcomes. Results from the Pooled Analysis of Five Trials from the International Global RESOLUTE Program. Impact of the New BioMime™ Sirolimus-Eluting Stent in Complex Patients of Daily Practice – Preliminary Results of the MeriT-2 Study, 2012
- TCT-649 Safety and Efficacy of Overlapping Second Generation Drug-Eluting Stents Based Upon 2-year Clinical Outcomes. Results from the Pooled Analysis of Five Trials from the International Global RESOLUTE Program. Impact of the New BioMime™ Sirolimus-Eluting Stent in Complex Patients of Daily Practice – Preliminary Results of the MeriT-2 Study, 2012
- TCT-649 Safety and Efficacy of Overlapping Second Generation Drug-Eluting Stents Based Upon 2-year Clinical Outcomes. Results from the Pooled Analysis of Five Trials from the International Global RESOLUTE Program. Impact of the New BioMime™ Sirolimus-Eluting Stent in Complex Patients of Daily Practice – Preliminary Results of the MeriT-2 Study, 2012
- Efficacy of Everolimus-Eluting Stent Implantation in Patients With Calcified Coronary Culprit Lesions: Two-Year Angiographic and Three-Year Clinical Results From the SPIRIT II Study, 2010
- A pooled gender-based analysis comparing the XIENCE V (R) everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis, 2010
- Mammary coronary artery anastomosis without cardiopulmonary bypass through mini-thoracotomy: one-year clinical experience 1 Presented at the 1st World Congress on Minimally Invasive Cardiac Surgery, Paris, May 30–31, 1997. 1, 1998
- Percutaneous intra-aortic balloon pulsation for management of life-threatening emergencies in an intensive coronary care unit, 1993
Field of Expertise
- Abdominal Aortic Aneurysm Surgey
- Abdominal Surgery
- Ablation Therapy
- Adrenalectomy (Adrenal Gland Removal)
- Aneurysm Surgery: Traditional Open Surgery
- Angiography
- Aorta Surgery
- Aortic Aneurysm Repair Surgery
- Aortic Valve Surgery
- Aortic Valve Surgery in the Young Patient
- Aortic Valve: Ross Procedure
- Arthrocentesis (Joint Aspiration)
- Arthroscopic Shoulder Decompression
- ASD/VSD Device Closure
- Attention Deficit Hyperactivity Disorder (ADHD) Stimulant Therapy
- Bacillus Calmette Guerin (BCG) Therapy
- Balloon Angioplasty Cost
- Balloon Atrial Septostomy
- Balloon Valvuloplasty Cost
- Biventricular Pacemaker
- Bladder Augmentation (Cystoplasty)
- Bladder Surgery
- Blepharoplasty
- Bone-Anchored Hearing Aids (BAHA)
- Brain Surgery
- Breast Augmentation
- Bunion Surgery
- Cardiac Devices for Patients with Heart Failure
- Cardiac Implant Closure Devices in Adults
- Cardiac Implantable Electronic Device Replacement
- Catheter Ablation
- Cervical Artificial Disk Replacement
- Chemotherapy
- Chiropractic Adjustment
- Cholecystectomy
- Circumcision
- Circumcision Revision
- Cognitive Behavioral Therapy (CBT)
- Complex Aorta Surgery
- Congenital Heart Disease Treatments
- Coronary Artery Bypass Surgery (CABG)
- Coronary Brachytherapy
- Corpus Callosotomy
- Cryotherapy
- CT Stent
- Cystolitholapaxy
- Dermabrasion
- Elbow Replacement Surgery
- Electrical Cardioversion
- Electroconvulsive Therapy
- Endoleak Treatments
- Endoscopic Gastrostomy
- EPS RFA Cardiac Treatment
- Mitral Valve Replacement Surgery
- Patent Ductus Arteriosus Ligation Surgery
- Ross Procedure
- Tetralogy of Fallot (TOF) Repair Surgery
- Tetralogy of Fallot Treatment
- Trans Aortic Valve Replacement
- Transcatheter Aortic Valve Implantation (TAVI)
- Transcatheter Valve Replacement
- Transesophageal Echocardiography (TEE)
- Abdominal Aortic Aneurysm
- ACL (Anterior Cruciate Ligament) Tears
- Acoustic Neuroma
- Acute Disseminated Encephalomyelitis (ADEM)
- Acute Flaccid Myelitis
- Acute Flaccid Myelitis
- Acute Tubular Necrosis
- Adhesive Capsulitis
- Adolescent Sports Injuries of the Knee
- Adrenal Disorders
- Adult Acquired Flatfoot
- Adult Hodgkins Lymphoma
- Adult Scoliosis
- Adult-Onset Still's Disease
- Adventitial Cystic Disease
- ALD (Adrenoleukodystrophy)
- Alzheimer's Disease
- Amplified Musculoskeletal Pain Syndrome (AMPS) in Children
- Angina
- Ankle Injury
- Ankylosing Spondylitis (AS)
- Aortic Aneurysm
- Aortic Coarctation
- Aortic Dissection
- Arachnoiditis
- Arrhythmia
- Arrhythmogenic Right Ventricular Dysplasia (ARVD)
- Arteriovenous Malformation (AVM)
- Arthritis
- Arthritis of the Thumb Base
- Astrocytoma
- Atherosclerosis
- Atrial Fibrillation (AFIB)
- Atrial Septal Defect (ASD)
- Atypical Hyperplasia
- Autism Spectrum Disorder
- Avoidant Personality Disorder
- Axillo-Subclavian Vein Thrombosis
- Azoospermia
- Bacillus Calmette Guerin (BCG) Treatment for Non-Muscle Invasive Bladder Cancer
- Back Pain in Athletes
- Back Strains and Sprains
- Back Strains and Sprains
- Down Syndrome
- Fetal Heart Disease
- Hyperlipidemia
- Portal Hypertension
- Thoracic Aortic Aneurysm
Best Cardiology Doctors in India

Dr. Sushil Kumbhat
Senior Consultant
Interventional Cardiologist
Nanavati Super Specialty Hospital, Mumbai


Dr. Shivanand S Patil
Senior Consultant
Interventional Cardiologist
Fortis Hospital, Bannerghatta Road, Bangalore


Dr. Ashok Seth
Chairman
Interventional Cardiologist
Fortis Escorts Heart Institute, New Delhi


Dr. Sushil Kumbhat
Senior Consultant
Interventional Cardiologist
Nanavati Super Specialty Hospital, Mumbai


Dr. Shivanand S Patil
Senior Consultant
Interventional Cardiologist
Fortis Hospital, Bannerghatta Road, Bangalore


Dr. Ashok Seth
Chairman
Interventional Cardiologist
Fortis Escorts Heart Institute, New Delhi


Dr. Sushil Kumbhat
Senior Consultant
Interventional Cardiologist
Nanavati Super Specialty Hospital, Mumbai
